Generali Investments Towarzystwo Funduszy Inwestycyjnych Has $156,000 Stake in MetLife, Inc. (NYSE:MET)

Generali Investments Towarzystwo Funduszy Inwestycyjnych trimmed its stake in MetLife, Inc. (NYSE:MET) by 9.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,900 shares of the financial services provider’s stock after selling 200 shares during the period. Generali Investments Towarzystwo Funduszy Inwestycyjnych’s holdings in MetLife were worth $156,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Swedbank AB grew its holdings in MetLife by 5.3% during the 3rd quarter. Swedbank AB now owns 1,970,163 shares of the financial services provider’s stock worth $162,499,000 after acquiring an additional 99,328 shares during the period. J.W. Cole Advisors Inc. grew its stake in shares of MetLife by 3.1% in the 3rd quarter. J.W. Cole Advisors Inc. now owns 5,918 shares of the financial services provider’s stock valued at $488,000 after buying an additional 178 shares during the period. Fortitude Family Office LLC grew its stake in shares of MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after buying an additional 266 shares during the period. Eagle Strategies LLC acquired a new stake in shares of MetLife in the 3rd quarter valued at about $213,000. Finally, Golden State Equity Partners bought a new position in MetLife in the 3rd quarter valued at about $205,000. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Stock Performance

MetLife stock opened at $84.08 on Friday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $58.22 billion, a PE ratio of 14.08, a P/E/G ratio of 0.65 and a beta of 1.07. The firm has a fifty day simple moving average of $83.56 and a two-hundred day simple moving average of $81.72. MetLife, Inc. has a twelve month low of $67.30 and a twelve month high of $89.05.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Research analysts expect that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.59%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s dividend payout ratio (DPR) is 36.52%.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. JPMorgan Chase & Co. raised their price target on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. BMO Capital Markets started coverage on shares of MetLife in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price objective for the company. TD Cowen lifted their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Finally, Barclays reduced their price target on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, February 7th. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.58.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.